www.fdanews.com/articles/85020-first-patient-enrolled-in-st-jude-medical-s-migraine-headache-study
FIRST PATIENT ENROLLED IN ST. JUDE MEDICAL'S MIGRAINE HEADACHE STUDY
March 3, 2006
St. Jude Medical, Inc. today announced the enrollment of the first patient in its ESCAPE (Effect of Septal Closure of Atrial PFO on Events of Migraine with Premere(TM)) migraine trial. The first patient, a Virginia woman, will be one of over 500 patients to participate in the study, which received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) in December 2005.
()a href="http://www.genengnews.com/news/bnitem.aspx?name=1183312XSL_NEWSML_TO_NEWSML.xml" target="_blank">Genetic Engineering News